Michael A Scarpone, Daniel Kuebler, David B Harrell.
Pilot Study | White Paper
In their pilot study Drs. Scarpone, Kuebler, and Harrell found that the number of TNCs and CFU‐f was greater than traditional aspirations of similar volumes and was comparable or greater than centrifuge‐based final products. The MARROW CELLUTION™ device produced results suggesting that it can effectively replace aspiration of large volumes of marrow using traditional needles combined with the volume reduction of centrifuge‐based systems.
The Marrow Cellution™ System is designed to minimize and eliminate the restrictive limitations associated with “point of care” processing systems which employ inefficient traditional aspiration trocar technology and are regulated as drugs “Advanced Therapies Medicinal Products (ATMP)”. Marrow Cellution™ is a minimally invasive bone/cell enriched autograft access and retrieval system, which does not require additional manipulation or processing, it never leaves the sterile field and provides rich autograft without associated morbidity.
Visit our Marrow Cellution product page